Corporate GovernanceJul 2, 2026, 05:12 PM
ADC Therapeutics Grants $2.9M Cash & 1.09M RSU Retention Awards to Executives
AI Summary
ADC Therapeutics SA's Board of Directors approved one-time retention awards for certain employees, including its named executive officers. These awards consist of approximately $2.9 million in cash incentives and 1.09 million Restricted Stock Units (RSUs). The cash portion is payable around July 15, 2026, with repayment conditions if employment ends before June 30, 2027, unless terminated without cause or for good reason. The RSUs will vest by June 30, 2027, under similar employment conditions.
Key Highlights
- CEO Ameet Mallik received a cash incentive award of $1,795,500 and 675,000 RSUs.
- CFO Jose Carmona received a cash incentive award of $541,842 and 203,700 RSUs.
- CMO Mohamed Zaki received a cash incentive award of $568,974 and 213,900 RSUs.
- Total cash awards amount to approximately $2.9 million.
- Total RSU awards amount to approximately 1.09 million units.
- Cash awards are subject to repayment if employment terminates before June 30, 2027, unless for cause or good reason.
- RSUs vest by June 30, 2027, or earlier upon termination without cause or for good reason.
Price Impact
More from ADCT